DexCom Inc (DXCM)

NASDAQ
84.69
-2.84(-3.24%)
  • Volume:
    952,727
  • Day's Range:
    84.12 - 87.72
  • 52 wk Range:
    66.89 - 164.86

DXCM Overview

Prev. Close
87.53
Day's Range
84.12-87.72
Revenue
2.67B
Open
86.7
52 wk Range
66.89-164.86
EPS
0.432
Volume
952,727
Market Cap
33.25B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
3,420,309
P/E Ratio
212.75
Beta
1.02
1-Year Change
-31.29%
Shares Outstanding
392,581,776
Next Earnings Date
02 Nov 2022
What is your sentiment on DexCom?
or
Vote to see community's results!

DexCom Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

DexCom Inc Analysis

DexCom Inc Company Profile

DexCom Inc Company Profile

DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for use by people with diabetes and by healthcare providers. Its Dexcom G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an application on the patient's mobile device to wirelessly transmit glucose information to the cloud and then to applications on the mobile devices of up to five designated recipients. Its Dexcom Real-Time API enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices. Its other products include Dexcom ONE and Dexcom G7.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellStrong SellStrong SellBuy
Technical IndicatorsStrong BuySellStrong SellSellStrong Sell
SummaryBuySellStrong SellStrong SellNeutral